Table 1.
Guideline Title [Reference] | Guideline Developer(s) | Countries or Regions | Year | Target Population | Guideline Fields |
---|---|---|---|---|---|
Guidance for national tuberculosis programmes on the management of tuberculosis in children [1] | WHO | International | 2006 | Children | Diagnosis Treatment |
Rapid advice. Treatment of tuberculosis in children [5] | WHO | International | 2010 | Children | Treatment |
Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: policy statement [6] | WHO | International | 2011 | Adults Children |
Diagnosis |
Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system [7] | WHO | International | 2011 | Adults Children |
Diagnosis |
Guidelines for the programmatic management of drug-resistant tuberculosis [8] | WHO | International | 2011 | Adults Children |
Treatment |
Desk-guide for diagnosis and management of TB in children [9] | IUATLD | International | 2010 | Children | Diagnosis Treatment |
Evaluation of Tuberculosis Diagnostics in Children [10,11] | Expert Panel | International | 2012 | Children | Diagnosis |
Tuberculosis (in: Red Book 2012) [12] | AAP | U.S. | 2012 | Children | Diagnosis Treatment |
Treatment of Tuberculosis [13] | ATS CDC IDSA |
U.S. | 2003 | Adults Children |
Treatment |
Diagnostic Standards and Classification of Tuberculosis in Adults and Children [14] | ATS CDC IDSA |
U.S. | 2000 | Adults Children |
Diagnosis |
Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis [15] | CDC | U.S. | 2009 | Adults Children |
Diagnosis |
Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection [16] | CDC | U.S. | 2010 | Adults Children |
Diagnosis |
Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection [17] | CDC | U.S. | 2011 | Adults Children |
Treatment |
European Union Standards for Tuberculosis Care [18] | ECDC ERS |
Europe | 2012 | Adults Children |
Diagnosis Treatment |
Use of interferon-gamma release assays in support of TB diagnosis [19] | ECDC | Europe | 2011 | Adults Children |
Diagnosis |
Management of contacts of MDR TB and XDR TB patients [20] | ECDC | Europe | 2012 | Adults Children |
Diagnosis Treatment |
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement [21] | TBNET | Europe | 2009 | Adults Children |
Diagnosis |
Clinical diagnosis and management of tuberculosis, and measures for its prevention and control [22] | NICE | U.K. | 2011 | Adults Children |
Diagnosis Treatment |
Diagnosis of tuberculosis in pediatrics. Consensus document of the Spanish Society of Pediatric Infectology (SEIP) and the Spanish Society of Pediatric Pneumology (SENP) [23] | SEIP SENP |
Spain | 2010 | Children | Diagnosis |
Consensus document for the treatment of pulmonar tuberculosis in children [24] | SEIP | Spain | 2007 | Children | Treatment |
Recommendations of the Spanish Society for Pediatric Infectious Diseases (SEIP) on the management of drug-resistant tuberculosis [25] | SEIP | Spain | 2009 | Children | Treatment |
Consensus document on treatment of tuberculosis exposure and latent tuberculosis infection in children [26] | SEIP | Spain | 2006 | Children | Treatment |
Recommendations for Therapy, Chemoprevention and Chemoprophylaxis of Tuberculosis in Adults and Children [27] | DZK DGP |
Germany | 2012 | Adult Children |
Treatment |
Childhood tuberculosis guidelines of the Southern African Society for Paediatric Infectious Diseases [28] | SASPID | South Africa | 2009 | Children | Diagnosis Treatment |
Consensus Statement on Childhood Tuberculosis [29] | IAP | India | 2010 | Children | Diagnosis Treatment |
Management of tuberculosis in children [30] | ASID APRG |
Australasia | 2000 | Children | Treatment |
Canadian Tuberculosis Standards 7th Edition [31] | PHAC CTS CLA |
Canada | 2013 | Adult Children |
Diagnosis Treatment |
Note. WHO: World Health Organization; IUATLD: International Union Against Tuberculosis and Lung Disease; AAP: American Academy of Pediatrics; ATS: American Thoracic Society; CDC: Center for Control Disease and Prevention; IDSA: Infectious Diseases Society of America; ECDC: European Center for Disease Control and Prevention; ERS: European Respiratory Society; NICE: National Institute for Health and Care Excellence; SEIP: Spanish Society for Paediatric Infectious Diseases; SENP: Spanish Society for Paediatric Respiratory Disease; DZK: German Central Committee against Tuberculosis; DGP: German Respiratory Society; SASPID: Southern African Society for Paediatric Infectious Diseases; IAP: Indian Academy of Pediatrics; ASID: Australasian Society for Infectious Diseases (Subgroup of Paediatric Infectious Disease); APRG: Australasian Paediatric Respiratory Group; PHAC: Public Health Agency of Canada; CTS: Canadian Thoracic Society; CLA: Canadian Lung Association.